Literature DB >> 9453311

Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells.

T Yamakawa1, S Eguchi, Y Yamakawa, E D Motley, K Numaguchi, H Utsunomiya, T Inagami.   

Abstract

Lysophosphatidylcholine (lyso-PC) has been implicated in atherogenesis and the inflammatory process. Although lyso-PC has been reported to contribute to the mitogenic effect of oxidized LDL on rat cultured vascular smooth muscle cells (VSMCs), the signaling mechanisms by which lyso-PC promotes its proliferation are poorly characterized. Mitogen-activated protein (MAP) kinases are important mediators involved in the intracellular network of interacting proteins that transduces extracellular cues to intracellular responses. We therefore examined the effect of lyso-PC on MAP kinase activation, proto-oncogene expression, and AP-1 binding activity using cultured rat VSMC. Marked activation of MAP kinase occurred within 10 minutes of lyso-PC treatment, whereupon rapid inactivation ensued. MAP kinase activation by lyso-PC was concentration-dependent (6.25 to 25 micromol/L). Pertussis toxin treatment did not affect lyso-PC-induced MAP kinase phosphorylation. Lyso-PC (25 micromol/L) also increased the mRNA expression of c-fos and c-jun genes. An electrophoretic mobility shift assay showed that AP-1 binding activity was enhanced by lyso-PC. To examine the upstream signaling of MAP kinase, we used several inhibitors on MAP kinase activation induced by lyso-PC. Although lyso-PC induced sustained increase in intracellular Ca2+ concentration, EGTA had no effect on MAP kinase activation induced by lyso-PC. However, protein kinase C inhibitor GF109203X and downregulation of protein kinase C activity by prolonged treatment with phorbol ester inhibited lyso-PC-induced MAP kinase activation. These data suggest that lyso-PC transmits its mitogenic activity through a MAP kinase-AP-1 pathway, which exists downstream of its protein kinase C activation in VSMCs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453311     DOI: 10.1161/01.hyp.31.1.248

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells.

Authors:  Kasey C Vickers; Fernando Castro-Chavez; Joel D Morrisett
Journal:  Atherosclerosis       Date:  2010-04-14       Impact factor: 5.162

2.  Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells.

Authors:  A Masamune; Y Sakai; M Yoshida; A Satoh; K Satoh; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

3.  In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways.

Authors:  M M Campos; G E Souza; J B Calixto
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

4.  Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase.

Authors:  Hiroshi Suenaga; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Epidermal-growth-factor receptor and metalloproteinases mediate thromboxane A2-dependent extracellular-signal-regulated kinase activation.

Authors:  Carole Gallet; Stéphanie Blaie; Sylviane Lévy-Toledano; Aïda Habib
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

6.  Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2007-07-05       Impact factor: 5.157

7.  Lysophosphatidylcholine exhibits selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages.

Authors:  Cheon Ho Park; Mee Ree Kim; Jong-Min Han; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2009-02-28       Impact factor: 1.880

8.  Lipidomic signatures of aortic media from patients with atherosclerotic and nonatherosclerotic aneurysms.

Authors:  Kosuke Saito; Hiroaki Yagi; Keiko Maekawa; Mitsuhiro Nishigori; Masaki Ishikawa; Sayaka Muto; Tsukasa Osaki; Yutaka Iba; Kenji Minatoya; Yoshihiko Ikeda; Hatsue Ishibashi-Ueda; Hitoshi Ogino; Hiroaki Sasaki; Hitoshi Matsuda; Yoshiro Saito; Naoto Minamino
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.